Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
951 studies found for:    glioblastoma
Show Display Options
RSS Create an RSS feed from your search for:
glioblastoma
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated
Has Results
TRC105 for Recurrent Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Drug: TRC105
2 Recruiting Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
Conditions: Glioblastoma;   Glioblastoma Multiforme;   Glioma;   Astrocytoma;   Brain Tumor
Interventions: Biological: Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy;   Biological: Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
3 Completed Evaluation of [18F]-FMISO for Non Operated Glioblastoma
Condition: Glioblastoma
Intervention: Procedure: 18F]-FMISO PET-CT
4 Completed
Has Results
6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
Conditions: Anaplastic Glioma of Brain;   Glioblastoma Multiforme;   Brain Cancer
Interventions: Drug: Capecitabine;   Drug: Celecoxib (Celebrex);   Drug: Temozolomide;   Drug: Lomustine;   Drug: 6-Thioguanine
5 Active, not recruiting Disease Progression and Treatment-induced Alterations in Glioblastoma
Condition: Brain Tumor
Intervention: Genetic: analyze systematically morphological and molecular changes associated with glioblastoma progression and therapy-resistance
6 Completed A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma
Intervention: Drug: PD 0332991
7 Recruiting Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
Condition: Glioblastoma Multiforme
Intervention: Other: ketogenic diet
8 Active, not recruiting Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: glioblastoma multiforme multipeptide vaccine IMA950;   Biological: sargramostim;   Drug: temozolomide;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: adjuvant therapy;   Radiation: radiation therapy
9 Unknown  A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
Condition: Glioblastoma
Intervention: Procedure: FDG-PET
10 Withdrawn Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)
Condition: Glioblastoma Multiforme
Intervention: Drug: IL-4PE
11 Active, not recruiting A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Patients With Recurrent Glioblastoma
Condition: Glioblastoma
Interventions: Drug: bevacizumab;   Drug: bevacizumab placebo;   Drug: onartuzumab;   Drug: onartuzumab placebo
12 Recruiting Phase II Pazopanib Plus Topotecan for Recurrent Glioblastoma Multiforme (GBM)
Conditions: Brain Neoplasms;   Central Nervous System Neoplasms
Interventions: Drug: Pazopanib;   Drug: Topotecan;   Behavioral: Symptom Questionnaire;   Behavioral: Phone Calls
13 Completed A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: MEDI-575
14 Completed Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Glioblastoma;   Gliosarcoma;   Malignant Gliomas
Interventions: Drug: lenalidomide;   Radiation: Radiation
15 Unknown  Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients
Condition: Glioblastoma
Intervention: Drug: Temozolomide
16 Recruiting Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention:
17 Withdrawn A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
Condition: Recurrent Glioblastoma
Interventions: Drug: TMZ plus concurrent re-irradiation;   Drug: Temozolomide
18 Terminated Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: TLN-4601
19 Active, not recruiting BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)
Conditions: GBM;   Glioblastoma Multiforme;   Gliosarcoma
Intervention: Drug: PSMA ADC
20 Suspended Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
Condition: Glioblastoma
Intervention: Drug: nelfinavir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years